| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Abbott Laboratories is at the forefront of medical innovation, particularly with breakthroughs such as the TriClip system, which significantly enhances treatment for heart valve conditions and improves patient outcomes. Their commitment to innovative medical technology is further demonstrated through the development of the Voltâ„¢ PFA System aimed at heart rhythm disorders. These advancements not only improve the quality of life for patients but also reflect the company's dedication to product innovation in healthcare. With a focus on developing new medical technologies, Abbott is poised for continued impact in the realm of product and service development. |
| The price action of Abbott Laboratories (ABT) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABT since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2025-03-31. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (4.4) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABT | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0%(0%) | 0 | 0% | 0.6 | 4.4 | -1 | |||||||
| 2025-03-28 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-03-27 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-03-26 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-03-25 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-03-24 | 0%(0%) | 0 | 0% | 0.4 | 3.3 | -1 | |||||||
| 2025-03-21 | 0%(0%) | 0 | 0% | 0.6 | 4.4 | -1 | |||||||
| 2025-03-18 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-03-17 | 0%(0%) | 0 | 0% | 0.3 | 3 | -1 | |||||||
| 2025-03-14 | 0%(0%) | 0 | 0% | 0.3 | 3 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-07-18 16:27:34 Improved quality of life and reduced severity of heart conditions reflect positive outcomes for patients using the TriClip system. |
| 2025-07-18 16:27:34 The presentation of pivotal trial data at a major conference indicates strong validation for Abbott's treatments. |
| 2025-07-18 16:27:34 The late-breaking data emphasizes the importance of new medical treatments in reducing hospitalizations and improving quality of life. |
| 2025-07-18 16:27:34 The TriClip system demonstrates significant innovation in treating heart valve conditions, leading to improved patient outcomes. |
| 2025-07-18 16:27:34 Abbott's stock performance shows a positive trend, outperforming the broader market. |